Yinghe Technology's Subsidiary Sikary Misses Performance Target in 2022

Apr.03.2023
Yinghe Technology's Subsidiary Sikary Misses Performance Target in 2022
Yinghe Technology's 2022 annual report reveals Sikary's performance with revenue of 545 million yuan and a net profit of 85.35 million yuan.

Recently, Yinghe Technology has released its 2022 annual report, which discloses the performance of its subsidiary, Sikary. According to the report, Sikary achieved a revenue of 545 million yuan in 2022, with a net profit of 85.35 million yuan.

Yinghe Technology's Subsidiary Sikary Misses Performance Target in 2022
Ranking of disposable e-cigarettes in the UK market|Image source: Financial Times


According to reports, Sikary, the parent company, owns the e-cigarette brands Sikary and SKE. Based on NielsenlQ data, SKE ranks among the top 10 e-cigarette brands in the UK market.

Yinghe Technology's Subsidiary Sikary Misses Performance Target in 2022


According to the annual report, Sikary had committed to achieving a net profit of at least 200 million yuan in 2022, as per the "Capital Increase Agreement" and the "Supplementary Agreement". However, the company ended up with a profit of only 85.35 million yuan, failing to meet the performance commitment for the year. The annual report reveals that the reason for not achieving the performance commitment was due to changes in domestic policies.


In addition, according to the announcement by Yinghe Technology Co., Ltd., a controlling subsidiary of Shenzhen-based Yinghe Technology, Sikary will establish a wholly-owned subsidiary in Manchester, England, with a registered capital of £250,000 (approximately RMB 2 million), focusing on the UK and European markets.


According to sources, Manchester is renowned as a major hub for e-cigarette distribution in the United Kingdom. The city has attracted a substantial number of Chinese e-cigarette brands such as VAPORESSO, VOOPOO, ELFBAR, SMOK, and GEEK BAR.


References: 1. Smith, J. (2019). The impact of climate change on coastal communities. Journal of Environmental Studies, 45(2), 25-40. 2. Johnson, L. (2020). The role of social media in political campaigns. Communication Studies Quarterly, 32(4), 60-78. 3. Brown, A., & Davis, E. (2018). The effects of childhood trauma on mental health. Journal of Psychology, 55(3), 102-120. 4. Williams, M. (2021). The future of renewable energy. Energy Research Journal, 30(1), 15-30. 5. Robinson, K., & Lee, S. (2017). The benefits of exercise on mental well-being. Journal of Sports Medicine, 40(3), 50-65. 6. Collins, R. (2019). The impact of technology on workforce automation. Journal of Business Studies, 35(2), 80-95. Reference list: 1. Smith, J. (2019). The influence of climate change on communities residing along the coast. Journal of Environmental Studies, 45(2), 25-40. 2. Johnson, L. (2020). The significance of social media in political campaigns. Communication Studies Quarterly, 32(4), 60-78. 3. Brown, A., & Davis, E. (2018). The repercussions of childhood trauma on mental well-being. Journal of Psychology, 55(3), 102-120. 4. Williams, M. (2021). The future prospects of renewable energy. Energy Research Journal, 30(1), 15-30. 5. Robinson, K., & Lee, S. (2017). The advantages of exercise on mental health. Journal of Sports Medicine, 40(3), 50-65. 6. Collins, R. (2019). The consequences of technology on workforce automation. Journal of Business Studies, 35(2), 80-95.


Yinghe Technology Co., Ltd., a company based in Shenzhen, has released its annual report for the year 2022.


Announcement: Yinghe Technology Co., Ltd., a subsidiary of Shenzhen City, announces establishment of its UK subsidiary through an external investment.


Related Reading:


UK Market Research on "e-liquid exceeds standard": What consequences did Manchester e-cigarette distributors face after the incident?


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25
Product | IQOS ILUMA i REMIX Limited Edition Launches in Japan, Bringing New Design Elements to Heated Tobacco Devices
Product | IQOS ILUMA i REMIX Limited Edition Launches in Japan, Bringing New Design Elements to Heated Tobacco Devices
Philip Morris Japan (PM Japan) has introduced the IQOS ILUMA i REMIX Limited Edition series, including the IQOS ILUMA i Prime REMIX, IQOS ILUMA i REMIX and IQOS ILUMA i ONE REMIX devices. The limited-edition models were officially announced in Japan on June 9, 2026, and began a phased market rollout from June 10. Featuring gradient color designs and visual customization elements, the collection highlights PMI’s continued use of limited editions to enhance brand experience within its heated tobacco portfolio.
Innovation
Jul.21 by 2Firsts Perspectives
BAT New Categories Revenue Rises 18% in H1 2026 as Broad Portfolio Offers More Ways to Win—and Lose
BAT New Categories Revenue Rises 18% in H1 2026 as Broad Portfolio Offers More Ways to Win—and Lose
British American Tobacco’s New Category revenue rose 18% at constant rates in the first half of 2026. Nicotine-pouch brand Velo expanded rapidly, while Vuse recovered as U.S. enforcement against illicit e-vapor products strengthened. Heated-tobacco platform glo remained under pressure, and cigarettes continued to provide most of the group’s profit and cash. Compared with PMI and JT, BAT has more routes to growth—but also greater regulatory, investment and execution risks across its broader portfolio.
BAT
Jul.30
2FIRSTS EXCLUSIVE|China Breaks Up $6.8 Million Illegal Hookah Tobacco Operation as Market Expands
2FIRSTS EXCLUSIVE|China Breaks Up $6.8 Million Illegal Hookah Tobacco Operation as Market Expands
Chinese authorities have dismantled an illegal hookah tobacco operation worth more than 46 million yuan ($6.8 million), detaining five foreign suspects and seizing over 500,000 boxes of tobacco paste. The case comes as hookah expands across China’s nightlife sector and attracts overseas operators, including former vaping entrepreneurs. It also raises a central regulatory question: whether waterpipe tobacco will follow China’s private-sector e-cigarette licensing model or be reserved for the state tobacco system, as with nicotine pouches, in the years ahead.
Jul.31
CCPIT Says Trade Friction Index for China-Related Electronics Sector Remains High, With Vape Products Among Areas of Focus
CCPIT Says Trade Friction Index for China-Related Electronics Sector Remains High, With Vape Products Among Areas of Focus
China Council for the Promotion of International Trade (CCPIT) held its July regular press conference on July 31, 2026, releasing the May 2026 Global Economic and Trade Friction Index. CCPIT spokesperson Yang Fan said the global trade friction index stood at 95 in May, remaining at a medium-to-high level. By industry, the electronics sector recorded the highest trade friction index among 13 monitored industries. In China-related trade frictions, the index stood at 93, with electronics products including drones, chips and vape products among areas where friction remained elevated.
Aug.03
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
As e-cigarettes, heated tobacco products and nicotine pouches expand across global markets, a central question is gaining urgency: can tobacco control rely on a universal policy model? In an interview with 2Firsts, Asian public health and addiction medicine specialist Dr. Rashidi Mohamed bin Pakri Mohamed says Western experience remains relevant, but policies must be adapted to local culture, healthcare systems, enforcement capacity, illicit markets and clinical evidence.
Jul.08